cetirizine has been researched along with Acute Disease in 14 studies
Cetirizine: A potent second-generation histamine H1 antagonist that is effective in the treatment of allergic rhinitis, chronic urticaria, and pollen-induced asthma. Unlike many traditional antihistamines, it does not cause drowsiness or anticholinergic side effects.
cetirizine : A member of the class of piperazines that is piperazine in which the hydrogens attached to nitrogen are replaced by a (4-chlorophenyl)(phenyl)methyl and a 2-(carboxymethoxy)ethyl group respectively.
Acute Disease: Disease having a short and relatively severe course.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The addition of a prednisone burst did not improve the symptomatic and clinical response of acute urticaria to levocetirizine." | 9.27 | Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial. ( Barniol, C; Charpentier, S; Dehours, E; Houze-Cerfon, CH; Lauque, D; Mallet, J, 2018) |
| "The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 7.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
| " Two-hundred and forty patients with acute urticaria admitted to emergency department will be randomised in a 1:1 ratio to receive levocetirizine or an association of levocetirizine and prednisone." | 5.30 | Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial. ( Adnet, F; Bagot, M; Berard, F; Bouillet, L; Casalino, E; Caux, F; Chosidow, O; Descamps, V; Doutre, MS; Fain, O; Fontaine, JP; Gil-Jardine, C; Goulet, H; Javaud, N; Khellaf, M; Lapostolle, F; Maignan, M; Martin, L; Pateron, D; Roy, PM; Soria, A; Tazarourte, K; Vicaut, E, 2019) |
| "The addition of a prednisone burst did not improve the symptomatic and clinical response of acute urticaria to levocetirizine." | 5.27 | Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial. ( Barniol, C; Charpentier, S; Dehours, E; Houze-Cerfon, CH; Lauque, D; Mallet, J, 2018) |
| "Our objective was to study the effect of long-term treatment with the H(1)-receptor antagonist cetirizine in the prevention of urticaria in young children with atopic dermatitis." | 5.09 | Prevention of acute urticaria in young children with atopic dermatitis. ( Simons, FE, 2001) |
| "A 26-year-old man was hospitalized with a week-long history of weakness, nausea, anorexia, and hyperchromic urine, which had developed after 6 days of therapy with oral cetirizine 10 mg/day for allergic rhinitis." | 3.72 | Recurrent acute hepatitis associated with use of cetirizine. ( Basso, M; Gasbarrini, G; Grieco, A; Pompili, M; Rapaccini, GL; Vecchio, FM, 2004) |
| "The paradoxical acute exacerbation of pre-existing chronic idiopathic urticaria accompanied by intense generalized pruritus, facial oedema, and dyspnoea in a 36-year-old-woman 3-4 h after a single oral dose of 10 mg cetirizine (Zyrtec tablets), suggested the presence of an underlying intolerance reaction." | 3.71 | Urticarial intolerance reaction to cetirizine. ( Damveld, B; Marsch, WC; Schröter, S, 2002) |
| " In the first group, only prednicarbat cream was applied to affected places twice a day for a maximum of 10 days, while in the other group also cetirizin was administered once a day in a dosage according to the patient's age." | 2.70 | [Prednicarbate and cetirizin dihydrochloride in the treatment of atopic eczema in the acute phase in children]. ( Bartosíková, L; Dzúrová, J; Frána, L; Frána, P; Kollár, P; Kotolová, H; Necas, J; Petrzelková, J, 2001) |
| "Montelukast has not been reported to have major effects on sneezing and itching in the clinic but reduces nasal obstruction (lower nasal airway pressure or nasal patency)." | 1.35 | Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs. ( Al Suleimani, YM; Dong, Y; Walker, MJ, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (50.00) | 29.6817 |
| 2010's | 6 (42.86) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Javaud, N | 1 |
| Soria, A | 1 |
| Maignan, M | 1 |
| Martin, L | 1 |
| Descamps, V | 1 |
| Fain, O | 1 |
| Bouillet, L | 1 |
| Berard, F | 1 |
| Tazarourte, K | 1 |
| Roy, PM | 1 |
| Fontaine, JP | 1 |
| Bagot, M | 1 |
| Khellaf, M | 1 |
| Goulet, H | 1 |
| Lapostolle, F | 1 |
| Casalino, E | 1 |
| Doutre, MS | 1 |
| Gil-Jardine, C | 1 |
| Caux, F | 1 |
| Chosidow, O | 1 |
| Pateron, D | 1 |
| Vicaut, E | 1 |
| Adnet, F | 1 |
| Barniol, C | 1 |
| Dehours, E | 1 |
| Mallet, J | 1 |
| Houze-Cerfon, CH | 1 |
| Lauque, D | 1 |
| Charpentier, S | 1 |
| Sharawat, IK | 1 |
| Dawman, L | 1 |
| Asero, R | 1 |
| Park, JH | 1 |
| Godbold, JH | 1 |
| Chung, D | 1 |
| Sampson, HA | 1 |
| Wang, J | 1 |
| Raghavendran, R | 1 |
| Shipman, AR | 1 |
| Langman, G | 1 |
| Vijayan, S | 1 |
| Orpin, SD | 1 |
| Pompili, M | 1 |
| Basso, M | 1 |
| Grieco, A | 1 |
| Vecchio, FM | 1 |
| Gasbarrini, G | 1 |
| Rapaccini, GL | 1 |
| Monroe, JR | 1 |
| Al Suleimani, YM | 1 |
| Dong, Y | 1 |
| Walker, MJ | 1 |
| Bartosíková, L | 1 |
| Frána, L | 1 |
| Necas, J | 1 |
| Frána, P | 1 |
| Dzúrová, J | 1 |
| Petrzelková, J | 1 |
| Kollár, P | 1 |
| Kotolová, H | 1 |
| Simons, FE | 1 |
| Fujii, K | 1 |
| Konishi, K | 1 |
| Kanno, Y | 1 |
| Ohgou, N | 1 |
| Schröter, S | 1 |
| Damveld, B | 1 |
| Marsch, WC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| COrticosteroids in acUte uRticAria in emerGency dEpartment[NCT03545464] | Phase 3 | 240 participants (Anticipated) | Interventional | 2019-09-21 | Recruiting | ||
| Glucocorticoids Associated With Antihistamines Versus Antihistamines Randomized Double Blinded for the Management of Acute Urticaria in Emergency[NCT02565680] | Phase 2/Phase 3 | 100 participants (Actual) | Interventional | 2012-02-29 | Completed | ||
| Adaptative Servoventilation Compliance in Left Ventricular Dysfunction Patients With Central Sleep Apnea: Benefit of One Month Hypnotic (Zopiclone) Versus Placebo[NCT02820441] | Phase 4 | 2 participants (Actual) | Interventional | 2016-05-31 | Terminated | ||
| [NCT02854397] | 31 participants (Actual) | Observational | 2016-02-15 | Terminated (stopped due to Recruitment difficulties) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
5 trials available for cetirizine and Acute Disease
| Article | Year |
|---|---|
Glucocorticoids for acute urticaria: study protocol for a double-blind non-inferiority randomised controlled trial.
Topics: Acute Disease; Adult; Cetirizine; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fol | 2019 |
Levocetirizine and Prednisone Are Not Superior to Levocetirizine Alone for the Treatment of Acute Urticaria: A Randomized Double-Blind Clinical Trial.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Cetirizine; Dou | 2018 |
Comparison of cetirizine and diphenhydramine in the treatment of acute food-induced allergic reactions.
Topics: Acute Disease; Adolescent; Anti-Allergic Agents; Cetirizine; Child; Child, Preschool; Diphenhydramin | 2011 |
[Prednicarbate and cetirizin dihydrochloride in the treatment of atopic eczema in the acute phase in children].
Topics: Acute Disease; Administration, Topical; Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; | 2001 |
Prevention of acute urticaria in young children with atopic dermatitis.
Topics: Acute Disease; Cetirizine; Child, Preschool; Dermatitis, Atopic; Double-Blind Method; Histamine H1 A | 2001 |
9 other studies available for cetirizine and Acute Disease
| Article | Year |
|---|---|
Intravenous Cetirizine (Quzyttir) for Acute Urticaria.
Topics: Acute Disease; Administration, Intravenous; Anti-Allergic Agents; Cetirizine; Humans; Urticaria | 2020 |
Acute Focal Dystonia After a Single Dose of Oral Cetirizine in a 9-Year-Old Boy.
Topics: Acute Disease; Anti-Allergic Agents; Anticonvulsants; Cetirizine; Child; Clonazepam; Dystonic Disord | 2019 |
Cetirizine premedication prevents acute urticaria induced by weak COX-1 inhibitors in multiple NSAID reactors.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Aged; Anti-Inflammatory Agents, Non-Steroida | 2010 |
Acute interstitial nephritis secondary to long-term use of cetirizine for the treatment of urticaria pigmentosa.
Topics: Acute Disease; Anti-Allergic Agents; Anti-Inflammatory Agents; Cetirizine; Histamine H1 Antagonists, | 2013 |
Recurrent acute hepatitis associated with use of cetirizine.
Topics: Acute Disease; Adult; Cetirizine; Chemical and Drug Induced Liver Injury; Histamine H1 Antagonists, | 2004 |
Acute episode or chronic problem?
Topics: Acute Disease; Angioedema; Cellulitis; Cetirizine; Chronic Disease; Dermatitis, Contact; Diagnosis, | 2007 |
Differential responses to various classes of drugs in a model of allergic rhinitis in guinea pigs.
Topics: Acetates; Acute Disease; Animals; Cetirizine; Cyclopropanes; Dexamethasone; Disease Models, Animal; | 2008 |
Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Cetirizine; Enzyme-Linked Immunosorbent | 2001 |
Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Cetirizine; Enzyme-Linked Immunosorbent | 2001 |
Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Cetirizine; Enzyme-Linked Immunosorbent | 2001 |
Acute urticaria with elevated circulating interleukin-6 is resistant to anti-histamine treatment.
Topics: Acute Disease; Adolescent; Adult; Anti-Inflammatory Agents; Cetirizine; Enzyme-Linked Immunosorbent | 2001 |
Urticarial intolerance reaction to cetirizine.
Topics: Acute Disease; Adult; Anti-Allergic Agents; Cetirizine; Chronic Disease; Drug Eruptions; Female; His | 2002 |